We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Predicting Survival After Liver Transplant

By HospiMedica staff writers
Posted on 20 Dec 2006
A new model based on specific characteristics of the donor and the recipient may help predict survival after liver transplantation, according to a new study.

George Ioannou, M.D., M.S., of the Veterans Affairs (VA) Puget Sound Health Care System (Seattle, WA, USA) sought to identify donor and recipient characteristics that are important predictors of graft survival following liver transplantation. More...
Using information provided by the U.S. united network for organ sharing (UNOS; Richmond, VA, USA), he identified all patients who had a liver transplant between 1994 and 2003. He did not include patients who had donors under age 10 or over age 75, living donors, split-liver donors, non-heart-beating donors, or donors with serum sodium concentration greater than 170 mmoles/l. He also excluded patients with multiple organ transplants, previous liver transplants, and incomplete information.

For the 20,301 patients who remained, including 6,477 with hepatitis C (HCV), Dr. Ioannou used statistical models to examine the relationship between donor and recipient characteristics and survival after transplant. He then created two models that predict survival after liver transplant--one for patients without HCV and one for those with HCV. He validated the models using data from patients not included in their derivation.

The study found that the donor age, cold ischemia time, recipient model end-stage liver disease (MELD) score, and cause of liver disease have the greatest impact on survival. However, the best model for patients without HCV included donor age, cold ischemia time, gender, race/ethnicity, recipient age, body mass index (BMI), MELD score, status at time of transplantation, diabetes mellitus, cause of liver disease, and serum albumin. For patients with HCV, the best model included the same donor characteristics, and all recipient characteristics except cause of liver disease and serum albumin. The findings were published in the November 2006 issue of Liver Transplantation.

"Risk scores and predicted survivals determined from such models may be an objective way to assess the risk of a given liver donor, recipient, or donor/recipient combination,” said Dr. Ioannou. "This model could be used to inform liver transplant candidates and their doctors what post-transplant survival would be expected when a given donor is offered and may be particularly helpful in marginal or high risk donors.”



Related Links:
Puget Sound Health Care System
United Network for Organ Sharing

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Exam Table
PF400
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.